|
Volumn 171, Issue 1, 2017, Pages 10-13
|
TOR, the Gateway to Cellular Metabolism, Cell Growth, and Disease
|
Author keywords
[No Author keywords available]
|
Indexed keywords
MAMMALIAN TARGET OF RAPAMYCIN;
MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1;
MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 2;
TARGET OF RAPAMYCIN KINASE;
TUBERIN;
ANTIFUNGAL AGENT;
RAPAMYCIN;
CELL GROWTH;
CELL METABOLISM;
DEGENERATIVE DISEASE;
DIABETES MELLITUS;
DISEASES;
MALIGNANT NEOPLASM;
NONHUMAN;
OBESITY;
PRIORITY JOURNAL;
SHORT SURVEY;
ANIMAL;
AWARDS AND PRIZES;
CELLS;
CHEMISTRY;
HISTORY;
HUMAN;
ISOLATION AND PURIFICATION;
METABOLISM;
NEOPLASMS;
PHYSIOLOGY;
SIGNAL TRANSDUCTION;
SWITZERLAND;
ANIMALS;
ANTIFUNGAL AGENTS;
AWARDS AND PRIZES;
CELLS;
HISTORY, 20TH CENTURY;
HUMANS;
NEOPLASMS;
PHYSIOLOGY;
SIGNAL TRANSDUCTION;
SIROLIMUS;
SWITZERLAND;
TOR SERINE-THREONINE KINASES;
|
EID: 85028879625
PISSN: 00928674
EISSN: 10974172
Source Type: Journal
DOI: 10.1016/j.cell.2017.08.019 Document Type: Short Survey |
Times cited : (69)
|
References (15)
|